Workflow
MIN FU INTL(08511)
icon
Search documents
民富国际(08511)委任夏荣华为行政总裁
智通财经网· 2025-08-11 11:12
Group 1 - The core point of the article is the leadership change at Minfu International, with Mr. Zeng Weijin resigning as CEO to focus on the group's development strategy, effective from August 11, 2025 [1] - Mr. Xia Ronghua has been appointed as the new CEO, also effective from August 11, 2025 [1]
民富国际(08511) - (1)有关透过收购目标公司发展农业食品科技及销售业务之业务更新;及(2)...
2025-08-11 11:06
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對 其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部份內 容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 (1)有關透過收購目標公司發展農業食品科技及 銷售業務之業務更新; 及 (2)行政總裁變更 Min Fu International Holding Limited 民富國際控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:8511) 有關透過收購目標公司發展農業食品科技及銷售業務之業務更新 謹此提述民富國際控股有限公司(「本公司」,連同其附屬公司統稱為「本集團」)日期為 2025年1月24日之公告(「該公告」),內容有關收購湖南省百升生物科技有限公司。除非 另有界定,否則本公告所用詞彙應與該公告所界定者具有相同涵義。 董事會欣然宣佈,收購事項已於2025年8月11日完成。於完成後,目標公司已成為本公司 之間接全資附屬公司。完成標誌著本集團正式開展農業食品科技及銷售業務之重要里 程碑。本公司相信,農業食品科技及銷售業務將成為新收入來源,為本集團之未來增長 作出貢獻。 1 行政總裁變更 夏先生為農 ...
民富国际(08511) - 截至二零二五年七月三十一日止股份发行人的证券变动月报表
2025-08-01 02:22
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 民富國際控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08511 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 125,000,000 | USD | | 0.004 | USD | | 500,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 125,000,000 | USD | | 0.004 | USD | | 500,000 | 本月底法定/註冊股本總額: USD ...
民富国际(08511) - 股东週年大会通告
2025-07-30 08:34
香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責,對其準確 性或完整性亦不發表任何聲明,並明確表示概不就因本通告全部或任何部份內容而產生或因 倚賴該等內容而引致之任何損失承擔任何責任。 Min Fu International Holding Limited 民富國際控股有限公司 2 4. 「動議: (a) 在下文(c)段的規限下,依據香港聯合交易所有限公司GEM證券上市規則(「GEM上 市規則」),一般及無條件批准董事於有關期間(定義見下文(d)段)行使本公司一切權 力以配發、發行及處理本公司股本中每股面值0.004美元的未發行股份(「股份」及各 為一股「股份」),並作出或授出可能須行使有關權力的要約、協議或購股權,包括可 認購股份的認股權證; (b) 上文(a)段所述的批准將授權董事於有關期間(定義見下文)作出或授出可能須在有 關期間屆滿後行使上述權力的要約、協議或購股權; (c) 本公司董事根據上文(a)段所述批准而配發及發行或同意有條件或無條件配發及發行 (不論是否根據購股權及其他情況)的股份總數不得超過下列兩者的總和,惟以下 情況除外:(i)供股(定義見下文);或(ii)行使根 ...
民富国际(08511) - 建议授出一般授权以发行及购回股份、重选董事、及股东週年大会通告
2025-07-30 08:33
閣下如對本通函任何方面或應採取的行動有任何疑問,應諮詢股票經紀或其他註冊證券商、 銀行經理、律師、專業會計師或其他專業顧問。 閣下如已出售或轉讓名下全部民富國際控股有限公司的股份,應立即將本通函連同隨附的 代表委任表格交予買主或承讓人,或經手買賣或轉讓的銀行、股票經紀或其他代理商,以便 轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函之內容概不負責,對其準 確性或完整性亦不發表任何聲明,並明確表示概不就因本通函全部或任何部份內容而產生 或因倚賴該等內容而引致之任何損失承擔任何責任。 Min Fu International Holding Limited 民富國際控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:8511) 建議授出一般授權以發行及購回股份、 重選董事、 及 股東週年大會通告 民富國際控股有限公司謹訂於2025年8月29日(星期五)上午十一時正假座香港上環文咸東街 35-45B號J Plus 2樓舉行股東週年大會,召開大會的通告載於本通函第20至25頁。 董事會函件載於本通函第4至9頁。 此乃要件 請即處理 無論 閣下能否出席股東週年大會,務請將隨附的代表 ...
民富国际(08511) - 2025 - 年度财报
2025-07-30 08:32
年報 2025 Annual Report 2025 ANNUAL REPORT 2025 年 報 香港聯合交易所有限公司(「聯交所」)GEM之特色 GEM的定位,乃為中小公司提供一個上市的市場,此等公司相比起其他在聯交所上市的公司帶有較高投資風 險。有意投資的人士應了解投資於該等公司的潛在風險,並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小公司,在GEM買賣的證券可能會較於主板買賣的證券承受較大的市場波動風 險,同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告之內容概不負責,對其準確性或完整性亦不發表任何聲明,並 明確表示概不就因本報告全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。本 報告載有有關民富國際控股有限公司(「本公司」)的資料,乃遵照聯交所GEM證券上巿規則(「GEM上市規則」) 而提供,本公司董事(統稱「董事」,各為一名「董事」)願就此共同及個別承擔全部責任。董事在作出一切合理查 詢後確認,就其所深知及盡信,本報告所載資料於所有重大方面均準確完整,並無誤導或欺騙,且並無遺漏其 他事宜致使本報告任何陳述或本 ...
民富国际(08511) - 2025 环境、社会及管治报告
2025-07-30 08:32
環境、社會及 管治報告 2025 Environmental, Social and Governance Report 2025 環境、社會及管治報告 關於本報告 民富國際控股有限公司(「本公司」)及其附屬公司(統稱「本集團」或「民富」)(股份代號:8511)主要在中華人民 共和國(「中國」)從事提供智能製造解決方案,包括銷售設備及提供有關技術服務。本公司股份(「股份」)於2018 年4月20日在聯交所GEM成功上市,是本集團的一個重要里程碑。本集團在中國專注於精密3D檢測解決方案及 精密加工解決方案。本公司為高端設備製造商提供智能製造解決方案,以滿足其在工業產品製造方面的高精 密需求。其解決方案包括及整合多種設備及服務,涵蓋從解決方案理念及設計、機械採購、輔助工具與軟件及 系統安裝與調試到提供技術支持及培訓等售後服務。本集團在中國亦從事殯葬代理服務業務。 本集團一直堅持開發新技術,包括新輔助工具設計軟件應用程式。於2025年3月31日,本集團總共擁有34項註 冊專利,包括8項發明專利及26項實用新型專利。 本集團深明有效的環境、社會及管治(「ESG」)措施對營運的重要性。本集團的ESG實踐方向受本公司董事 ...
民富国际(08511) - 2025 - 年度业绩
2025-06-27 08:31
本公告載有有關民富國際控股有限公司(「本公司」)的資料,乃遵照聯交所GEM證券上 巿規則(「GEM上市規則」)而提供,本公司董事(統稱「董事」,各為一名「董事」)願就此共 同及個別承擔全部責任。董事在作出一切合理查詢後確認,就其所深知及盡信,本公告 所載資料於所有重大方面均準確完整,並無誤導或欺騙,且並無遺漏其他事宜致使本公 告任何陳述或本公告產生誤導。 1 香港交易及結算所有限公司及聯交所對本公告之內容概不負責,對其準確性或完整性 亦不發表任何聲明,並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 Min Fu International Holding Limited 民富國際控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:8511) 截至2025年3月31日止年度的年度業績公告 香港聯合交易所有限公司(「聯交所」)GEM之特色 GEM的定位,乃為中小公司提供一個上市的市場,此等公司相比起其他在聯交所上市 的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險,並應經 過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小 ...
民富国际(08511) - 2025 - 年度业绩
2025-06-26 12:56
[Financial Performance](index=2&type=section&id=Financial%20Performance) [Consolidated Financial Statements](index=2&type=section&id=Consolidated%20Financial%20Statements) The company's FY2025 performance significantly declined, with revenue down 65.4% and loss for the year expanding to 27.331 million HKD, reflecting severe operational and financial pressure [Consolidated Statement of Comprehensive Income](index=2&type=section&id=Consolidated%20Statement%20of%20Comprehensive%20Income) Revenue for the year ended March 31, 2025, significantly decreased by 65.4% to 27.829 million HKD, leading to an expanded loss for the year of 27.331 million HKD and increased basic loss per share Consolidated Statement of Comprehensive Income Summary (thousand HKD) | Indicator | 2025 | 2024 | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Revenue | 27,829 | 80,501 | -65.4% | | Gross Profit | 2,549 | 17,558 | -85.5% | | Operating Loss | (28,359) | (17,407) | +62.9% | | Loss for the Year | (27,331) | (20,256) | +34.9% | | Loss Attributable to Owners of the Company | (27,331) | (20,098) | +36.0% | | Basic Loss Per Share (HKD) | (1.29) | (1.25) | +3.2% | [Consolidated Balance Sheet](index=4&type=section&id=Consolidated%20Balance%20Sheet) As of March 31, 2025, total assets decreased by 42.4% to 27.820 million HKD, total equity fell to 8.902 million HKD, and cash and cash equivalents plummeted, indicating severe liquidity pressure Consolidated Balance Sheet Summary (thousand HKD) | Indicator | March 31, 2025 | March 31, 2024 | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Total Assets | 27,820 | 48,319 | -42.4% | | Total Liabilities | 18,918 | 18,845 | +0.4% | | Total Equity | 8,902 | 29,474 | -69.8% | | Cash and Cash Equivalents | 223 | 14,676 | -98.5% | | Net Current Assets | 8,902 | 22,604 | -60.6% | [Notes to the Financial Statements](index=5&type=section&id=Notes%20to%20the%20Financial%20Statements) Notes to the financial statements highlight significant going concern uncertainties, with equipment manufacturing and funeral services as primary businesses, and all revenue and non-current assets derived from China [Basis of Preparation & Going Concern](index=5&type=section&id=Basis%20of%20Preparation%20%26%20Going%20Concern) The company's 27.331 million HKD loss and 0.223 million HKD cash balance at year-end indicate significant going concern uncertainties, despite management's plans for financial support, fundraising, and cost-saving measures - The company recorded an annual loss of approximately **27.331 million HKD**, with cash and cash equivalents at year-end of only approximately **0.223 million HKD**, indicating significant going concern uncertainties[9](index=9&type=chunk) - Response measures include: (a) obtaining a financial support letter from Executive Director Ms. Yip Ka Ling; (b) considering fundraising activities; and (c) implementing cost-saving measures[11](index=11&type=chunk) [Segment Information](index=9&type=section&id=Segment%20Information) The Group's business segments, equipment manufacturing and funeral services, reported revenues of 26.309 million HKD and 1.520 million HKD respectively in FY2025, with equipment manufacturing being the main revenue source and primary contributor to losses, all derived from China FY2025 Segment Results (thousand HKD) | Segment | Revenue | Segment Loss | | :--- | :--- | :--- | | Equipment Manufacturing Business | 26,309 | (21,267) | | Funeral Services Business | 1,520 | (2,550) | | **Total** | **27,829** | **(23,817)** | - Compared to FY2024, equipment manufacturing business revenue significantly decreased from **78.450 million HKD**, and losses expanded from **10.119 million HKD**[20](index=20&type=chunk) [Revenue and Expense Analysis](index=12&type=section&id=Revenue%20and%20Expense%20Analysis) Total revenue decreased by 65.4% to 27.829 million HKD, driven by a sharp decline in equipment sales, while total operating expenses decreased to 46.619 million HKD due to reduced inventory and other operating costs Revenue Composition (thousand HKD) | Business Type | 2025 | 2024 | | :--- | :--- | :--- | | Equipment Manufacturing - Equipment Sales | 26,309 | 75,981 | | Equipment Manufacturing - Technical Services | – | 2,469 | | Funeral Services Business | 1,520 | 2,051 | | **Total** | **27,829** | **80,501** | Key Expense Items (thousand HKD) | Expense Item | 2025 | 2024 | | :--- | :--- | :--- | | Cost of Inventories Recognized as Expense | 25,280 | 62,943 | | Staff Costs | 8,528 | 10,034 | | Professional Fees | 5,372 | 1,740 | | Outsourced R&D Expenses | 1,028 | 5,022 | [Loss Per Share and Dividends](index=15&type=section&id=Loss%20Per%20Share%20and%20Dividends) Loss attributable to owners of the company was 27.331 million HKD, resulting in a basic loss per share of **HKD 1.29**, with no dividends recommended by the Board - Basic loss per share was **HKD 1.29**, an increase from **HKD 1.25** last year[27](index=27&type=chunk)[5](index=5&type=chunk) - No dividends were paid or recommended for the year ended March 31, 2025[28](index=28&type=chunk) [Management Discussion and Analysis](index=17&type=section&id=Management%20Discussion%20and%20Analysis) [Business and Financial Review](index=17&type=section&id=Business%20and%20Financial%20Review) China's economic slowdown led to a **65.4% revenue decline** in smart manufacturing solutions and a reduced gross profit margin, resulting in a **34.9% expansion of loss for the year to 27.3 million HKD** due to lower gross profit and impairment losses - Smart manufacturing solutions services are the Group's core business, focusing on precision 3D inspection and processing solutions, with **5 new projects secured**, **4 completed**, and **34 registered patents** during the year[30](index=30&type=chunk)[31](index=31&type=chunk) - Revenue reduction was primarily due to economic fluctuations and China's economic slowdown, causing potential customers to postpone investment budgets for smart manufacturing solutions[32](index=32&type=chunk) - The increase in loss for the year was mainly due to the combined effect of impairment losses on trade receivables and reduced gross profit[39](index=39&type=chunk) [Liquidity and Capital Structure](index=19&type=section&id=Liquidity%20and%20Capital%20Structure) The company faces severe liquidity, with cash and cash equivalents at **200 thousand HKD** and significantly reduced net current assets, having conducted two placings and a share consolidation to raise **6.864 million HKD** for working capital - As of March 31, 2025, the Group's cash and cash equivalents were approximately **200 thousand HKD**, compared to **14.7 million HKD** in the prior year; net current assets were approximately **8.9 million HKD**, compared to **22.6 million HKD** last year[40](index=40&type=chunk) - Two placings were completed during the year, in August and December 2024, raising a total net proceeds of approximately **6.864 million HKD**[44](index=44&type=chunk)[47](index=47&type=chunk) - A **40-to-1 share consolidation** was completed on October 3, 2024[46](index=46&type=chunk) - The net proceeds from both placings have been fully utilized as planned for general working capital[50](index=50&type=chunk)[51](index=51&type=chunk) [Risk Management and Future Outlook](index=23&type=section&id=Risk%20Management%20and%20Future%20Outlook) The Group faces foreign exchange risk from USD and CHF fluctuations without a hedging policy, and plans to enter the agri-food technology market by acquiring Hunan Baisheng Biotechnology Co., Ltd. to diversify business growth - The Group faces foreign exchange risk from USD and CHF, recording a **100 thousand HKD loss** in other comprehensive loss due to exchange rate fluctuations[55](index=55&type=chunk) - The future strategic focus is to enter the agri-food technology market, with an agreement signed in January 2025 to acquire Hunan Baisheng Biotechnology Co., Ltd[56](index=56&type=chunk) [Corporate Governance and Other Information](index=25&type=section&id=Corporate%20Governance%20and%20Other%20Information) [Corporate Governance and Compliance](index=26&type=section&id=Corporate%20Governance%20and%20Compliance) The company maintains high corporate governance standards but deviates by having the Chairman and CEO as the same person, and briefly failed to meet GEM Listing Rules for independent non-executive directors, which was later rectified - The company deviates from corporate governance code by not separating the roles of Chairman and CEO, both held by Mr. Tsang Wai Kam, which the company believes provides strong leadership[63](index=63&type=chunk) - Due to a director's resignation, the company failed to comply with several GEM Listing Rules regarding the number and composition of independent non-executive directors from February 2 to May 2, 2024, but the issue has been resolved[64](index=64&type=chunk) [Auditor's Report Summary](index=28&type=section&id=Auditor%27s%20Report%20Summary) The auditor's report highlights significant going concern uncertainties due to the Group's annual loss and low cash levels, yet an unmodified opinion was issued on this matter - The auditor's report draws attention to significant uncertainties regarding going concern, noting the Group's annual loss of approximately **27.331 million HKD** and year-end cash level of approximately **0.223 million HKD** may cast significant doubt on its ability to continue as a going concern[69](index=69&type=chunk) - Despite significant uncertainties, the auditor issued an **unmodified opinion** on this matter[69](index=69&type=chunk) [Other Disclosures](index=25&type=section&id=Other%20Disclosures) As of March 31, 2025, the Group had **32 employees**, with no purchases, sales, or redemptions of listed securities during the year, no dividends recommended, and no significant post-reporting period events - As of March 31, 2025, the Group had **32 employees**, with competitive remuneration packages and share option schemes[61](index=61&type=chunk) - No purchases, sales, or redemptions of the company's listed securities occurred during the year[62](index=62&type=chunk) - The Board did not recommend the payment of a final dividend[66](index=66&type=chunk) - No significant disclosable post-reporting period events occurred from March 31, 2025, to the date of this announcement[67](index=67&type=chunk)
民富国际(08511.HK)5月2日收盘上涨29.63%,成交6.85万港元
Jin Rong Jie· 2025-05-02 08:32
Group 1 - The core viewpoint of the news is that Minfu International Holdings Limited (08511.HK) has shown significant stock price movement, with a recent increase of 29.63% despite a cumulative decline of 6.09% over the past month [1] - As of September 30, 2024, Minfu International reported total revenue of 12.42 million yuan, representing a year-on-year growth of 11.2%, while the net profit attributable to shareholders was -8.84 million yuan, a decrease of 26.88% [1] - The company's gross profit margin stands at 2.99%, and its debt-to-asset ratio is 35.82% [1] Group 2 - Minfu International, originally known as Zhicheng Technology Group, focuses on intelligent manufacturing solutions, particularly in precision 3D inspection and processing solutions [2] - The company aims to expand its business into smart manufacturing and digital upgrade solutions, specifically targeting the cemetery industry in mainland China [2] - Minfu International provides customized one-stop solutions for cemetery enterprises, helping them achieve digital upgrades and carbon neutrality through integrated hardware and software solutions [2]